Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
In a head-to-head trial against semaglutide (the SURPASS-2 trial), tirzepatide produced significantly greater weight loss, with participants taking the highest dose of tirzepatide losing an average of 11.2 kg (24.7 lbs), compared to 5.7 kg (12.5 lbs) for those taking semaglutide 1 mg
Prices vary by pharmacy and insurance coverage
Despite the rise in popularity of injectable weight-loss drugs such as Ozempic, many patients are hesitant to turn to medications to help them achieve their weight-loss goals
That translates into fewer stents, fewer knee replacements and more fulfilling lives
TRIUMPH-3 and the Cardiovascular Data (Where I Need to Correct Myself) In June I wrote that TRIUMPH-3 was critical because cardiovascular outcomes data will likely be required for full regulatory approval. I was half right, and I want to fix that in public
US$ 21.13
US$ 20.28
US$ 26.51
US$ 26.24
US$ 23.24
US$ 25.56
US$ 25.64
US$ 26.97
US$ 20.91
